Kyowa Kirin Co., Ltd. (4151.T)
JPY 2393.0
(0.46%)
JPY 2393.0
(0.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 117.59 Billion JPY | 34.2% |
| 2022 | 82.81 Billion JPY | 8.02% |
| 2021 | 79.86 Billion JPY | 10.46% |
| 2020 | 74.7 Billion JPY | 13.04% |
| 2019 | 70.83 Billion JPY | -33.57% |
| 2018 | 83.65 Billion JPY | 23.4% |
| 2017 | 84.53 Billion JPY | 21.79% |
| 2016 | 67.06 Billion JPY | -14.43% |
| 2015 | 80.32 Billion JPY | 11.45% |
| 2014 | 72.88 Billion JPY | -19.15% |
| 2013 | 84.94 Billion JPY | 0.16% |
| 2012 | 78.16 Billion JPY | -29.36% |
| 2011 | 79.86 Billion JPY | 0.83% |
| 2010 | 74.61 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 60.09 Billion JPY | 110.35% |
| 2007 | 53.48 Billion JPY | 41.07% |
| 2006 | 33.77 Billion JPY | 8.28% |
| 2005 | 34.84 Billion JPY | -18.39% |
| 2004 | 40.7 Billion JPY | -13.43% |
| 2003 | 27.53 Billion JPY | 56.53% |
| 2002 | 33.47 Billion JPY | -36.65% |
| 2001 | 33.39 Billion JPY | 5.12% |
| 2000 | 43.5 Billion JPY | 17.02% |
| 1999 | 44.67 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 32.33 Billion JPY | 4.74% |
| 2024 Q1 | 22.1 Billion JPY | -45.0% |
| 2024 Q2 | 30.99 Billion JPY | 40.49% |
| 2023 Q2 | 15.51 Billion JPY | -24.09% |
| 2023 FY | - JPY | 34.2% |
| 2023 Q3 | 43.97 Billion JPY | 183.47% |
| 2023 Q1 | 20.43 Billion JPY | 76.96% |
| 2023 Q4 | 42.89 Billion JPY | -2.45% |
| 2022 Q3 | 22.32 Billion JPY | -15.94% |
| 2022 Q4 | 11.54 Billion JPY | -48.26% |
| 2022 Q1 | 23.93 Billion JPY | -0.43% |
| 2022 Q2 | 26.55 Billion JPY | 10.97% |
| 2022 FY | - JPY | 8.02% |
| 2021 Q3 | 16.33 Billion JPY | -16.72% |
| 2021 FY | - JPY | 10.46% |
| 2021 Q1 | 20.91 Billion JPY | 40.63% |
| 2021 Q2 | 19.61 Billion JPY | -6.21% |
| 2021 Q4 | 24.03 Billion JPY | 47.13% |
| 2020 Q1 | 20.28 Billion JPY | 29.71% |
| 2020 Q2 | 19.94 Billion JPY | -1.68% |
| 2020 Q3 | 17.92 Billion JPY | -10.11% |
| 2020 Q4 | 14.87 Billion JPY | -17.04% |
| 2020 FY | - JPY | 13.04% |
| 2019 Q2 | 15.18 Billion JPY | -11.6% |
| 2019 Q1 | 17.17 Billion JPY | -0.83% |
| 2019 FY | - JPY | -33.57% |
| 2019 Q4 | 15.63 Billion JPY | -5.77% |
| 2019 Q3 | 16.59 Billion JPY | 9.28% |
| 2018 Q3 | 22.87 Billion JPY | 8.17% |
| 2018 Q4 | 17.32 Billion JPY | -24.29% |
| 2018 FY | - JPY | 23.4% |
| 2018 Q1 | 35.9 Billion JPY | 20.69% |
| 2018 Q2 | 21.15 Billion JPY | -41.09% |
| 2017 Q3 | 14.78 Billion JPY | -36.52% |
| 2017 Q2 | 23.29 Billion JPY | 24.17% |
| 2017 Q1 | 18.75 Billion JPY | 2.48% |
| 2017 FY | - JPY | 21.79% |
| 2017 Q4 | 29.74 Billion JPY | 101.19% |
| 2016 Q3 | 14.54 Billion JPY | 109.19% |
| 2016 FY | - JPY | -14.43% |
| 2016 Q4 | 18.3 Billion JPY | 25.85% |
| 2016 Q2 | 6.95 Billion JPY | -40.5% |
| 2016 Q1 | 11.68 Billion JPY | -33.66% |
| 2015 Q4 | 17.61 Billion JPY | -11.51% |
| 2015 Q1 | 10.78 Billion JPY | -43.67% |
| 2015 Q2 | 15.17 Billion JPY | 40.72% |
| 2015 FY | - JPY | 11.45% |
| 2015 Q3 | 19.9 Billion JPY | 31.16% |
| 2014 Q4 | 19.14 Billion JPY | 64.12% |
| 2014 FY | - JPY | -19.15% |
| 2014 Q3 | 11.66 Billion JPY | 43.82% |
| 2014 Q2 | 8.11 Billion JPY | -44.93% |
| 2014 Q1 | 14.72 Billion JPY | -32.69% |
| 2013 Q4 | 21.87 Billion JPY | 36.53% |
| 2013 FY | - JPY | 0.16% |
| 2013 Q1 | 17.45 Billion JPY | 136.56% |
| 2013 Q2 | 14.51 Billion JPY | -16.81% |
| 2013 Q3 | 16.02 Billion JPY | 10.4% |
| 2012 Q2 | 36.91 Billion JPY | -13.85% |
| 2012 Q3 | 36.5 Billion JPY | -1.11% |
| 2012 Q4 | -47.72 Billion JPY | -230.73% |
| 2012 FY | - JPY | -29.36% |
| 2012 Q1 | 42.85 Billion JPY | 495.93% |
| 2011 Q1 | 52.19 Billion JPY | 844.44% |
| 2011 Q4 | -10.82 Billion JPY | -126.75% |
| 2011 FY | - JPY | 0.83% |
| 2011 Q3 | 40.45 Billion JPY | 9.95% |
| 2011 Q2 | 36.79 Billion JPY | -29.51% |
| 2010 Q1 | 39.86 Billion JPY | 0.0% |
| 2010 Q4 | -7.01 Billion JPY | -116.51% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q3 | 42.46 Billion JPY | 0.36% |
| 2010 Q2 | 42.31 Billion JPY | 6.15% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q2 | 40.85 Billion JPY | 0.0% |
| 2009 Q3 | 39.62 Billion JPY | -3.01% |
| 2008 FY | - JPY | 110.35% |
| 2008 Q3 | 41.85 Billion JPY | -17.35% |
| 2008 Q2 | 50.63 Billion JPY | 0.0% |
| 2007 FY | - JPY | 41.07% |
| 2006 FY | - JPY | 8.28% |
| 2005 FY | - JPY | -18.39% |
| 2004 FY | - JPY | -13.43% |
| 2003 FY | - JPY | 56.53% |
| 2002 FY | - JPY | -36.65% |
| 2001 FY | - JPY | 5.12% |
| 2000 FY | - JPY | 17.02% |
| 1999 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Astellas Pharma Inc. | 195.34 Billion JPY | 39.802% |
| Chugai Pharmaceutical Co., Ltd. | 470.91 Billion JPY | 75.029% |
| Ono Pharmaceutical Co., Ltd. | 178.43 Billion JPY | 34.099% |
| Santen Pharmaceutical Co., Ltd. | 56.45 Billion JPY | -108.282% |
| JCR Pharmaceuticals Co., Ltd. | 10.72 Billion JPY | -996.001% |
| Daiichi Sankyo Company, Limited | 305.45 Billion JPY | 61.504% |
| Otsuka Holdings Co., Ltd. | 224.19 Billion JPY | 47.551% |
| Perseus Proteomics Inc. | -892 Million JPY | 13282.735% |